Which treatment worked better for whom? Moderators of group cognitive behavioral therapy versus adapted mindfulness based stress reduction for anxiety disorders

Behaviour Research and Therapy

Volumn 51, Issue 8, 2013, Pages 434-442

  Arch, Joanna J ^a   Ayers, Catherine R ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety disorders; Anxiety sensitivity; Cognitive behavioral therapy (CBT); Depression; Mindfulness based stress reduction (MBSR); Moderation

Indexed keywords

ADAPTED MINDFULNESS BASED STRESS REDUCTION; ADULT; AGED; ANXIETY; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DSM-IV; FEMALE; FOLLOW UP; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; CLINICAL COMPETENCE; COGNITIVE THERAPY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MINDFULNESS; PSYCHOTHERAPY, GROUP; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84879388717     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2013.04.004     Document Type: Article

References (42)

1. Aiken L.S., West S.G. Multiple regression: Testing and interpreting interactions 1991, Sage, Newbury Park, CA.
2. Arch J.J., Ayers C.R., Baker A., Almklov E., Dean D.J., Craske M.G. Randomized clinical trial of adapted mindfulness based stress reduction versus group cognitive behavioral therapy for heterogeneous anxiety disorders. Behaviour Research and Therapy 2013, 51(4-5):185-196.
3. Arch J.J., Craske M.G. Acceptance and commitment therapy and cognitive behavioral therapy for anxiety disorders: different treatments, similar mechanisms?. Clinical Psychology: Science and Practice 2008, 15(4):263-279.
4. Arch J.J., Eifert G.H., Davies C., Plumb J.C., Rose R.D., Craske M.G. Randomized clinical trial of cognitive behavioral therapy versus acceptance and commitment therapy for the treatment of mixed anxiety disorders. Journal of Consulting and Clinical Psychology 2012, 80(5):750-765.
5. Barlow D.H., Allen L.B., Choate M.L. Toward a unified treatment for emotional disorders. Behavior Therapy 2004, 35(2):205-230.
6. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck depression inventory-II 1996, Psychological Corporation, San Antonio, TX.
7. Brown T.A., Campbell L.A., Lehman C.L., Grisham J.R., Mancill R.B. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. Journal of Abnormal Psychology 2001, 110(4):585-599.
8. Brown K.W., Ryan R.M. The benefits of being present: mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology 2003, 84(4):822-848.
9. Craske, M. G. (2005). Cognitive-behavioral treatment of anxiety disorders. (unpublishedmanuscript).
10. Craske M.G., DeCola J.P., Sachs A.D., Pontillo D.C. Panic control treatment for agoraphobia. Journal of Anxiety Disorders 2003, 17(3):321-333.
11. Craske M.G., Farchione T.J., Allen L.B., Barrios V., Stoyanova M., Rose R. Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more?. Behaviour Research and Therapy 2007, 45(6):1095-1109.
12. Craske M.G., Rauch S.L., Ursano R., Prenoveau J., Pine D.S., Zinbarg R.E. What is an anxiety disorder?. Depression and Anxiety 2009, 26:1066-1085.
13. Craske M.G., Rose R.D., Lang A., Welch S.S., Campbell-Sills L., Sullivan G., et al. Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings. Depression and Anxiety 2009, 26(3):235-242.
14. Craske M.G., Stein M.B., Sullivan G., Sherbourne C., Bystritsky A., Rose R.D., et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Archives of General Psychiatry 2011, 68(4):378-387. 10.1001/archgenpsychiatry.2011.25.
15. Davies, C., Niles, A. N., Pittig, A., Arch, J. J., & Craske, M. G. (2013). Physiological and behavioral predictors of treatment outcome for anxiety disorders. (submitted for publication).
16. Eifert G.H., Forsyth J.P. Acceptance and commitment therapy for anxiety disorders: A practitioner's treatment guide to using mindfulness, acceptance, and values-based behavior change strategies 2005, Guilford Press, New York, NY.
17. Fresco D.M., Moore M.T., Van Dulmen M.H.M., Segal Z.V., Ma S.H., Teasdale J.D., et al. Initial psychometric properties of the experiences questionnaire: Validation of a self-report measure of decentering. Behavior Therapy 2007, 38(3):234-246.
18. Hayes S.C., Luoma J.B., Bond F.W., Masuda A., Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behaviour Research and Therapy 2006, 44(1):1-25.
19. Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and commitment therapy: An experiential approach to behavior change 1999, Guilford Press, New York, NY.
20. Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and commitment therapy: The process and practice of mindful change 2012, NY Guilford Press, New York. 2nd ed.
21. Kabat-Zinn J. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness 1990, Delta, New York, NY.
22. Kampfe C.K., Gloster A.T., Wittchen H.U., Helbig-Lang S., Lang T., Gerlach A.L., et al. Experiential avoidance and anxiety sensitivity in patients with panic disorder and agoraphobia: do both constructs measure the same?. International Journal of Clinical and Health Psychology 2012, 12(1):5-22.
23. Kampman M., Keijsers G.P.J., Hoogduin C.A.L., Hendriks G.-J. Outcome prediction of cognitive behavioral therapy for panic disorder: initial symptom severity is predictive for treatment outcome, comorbid anxiety or depressive disorder, cluster C personality disorders and initial motivation are not. Behavioural and Cognitive Psychotherapy 2008, 36:99-112.
24. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-Month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):617-627.
25. Kraemer H.C., Frank E., Kupfer D.J. Moderators of treatment outcome: clinical, research and policy importance. Journal of the American Medical Association 2006, 296(10):1286-1289.
26. Kraemer H.C., Wilson T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002, 59(10):877-883.
27. Marchand A., Belleville G.v., Fleet R., Dupuis G., Bacon S.L., Poitras J., et al. Treatment of panic in chest pain patients from emergency departments: efficacy of different interventions focusing on panic management. General Hospital Psychiatry 2012, 34(6):671-680.
28. Marks I.M., Swinson R.P., Basaglu M., Kuch K., Nasirvani H., O'Sullivan G., et al. Alprazolam and exposure along and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. British Journal of Psychiatry 1993, 162:776-787.
29. Peterson R.A., Reiss S. Anxiety sensitivity index manual 1992, International Diagnostic Systems, Worthington, OH. 2nd ed.
30. Ramel W., Goldin P.R., Carmona P.E., McQuaid J.R. The effects of mindfulness meditation on cognitive processes and affect in patients with past depression. Cognitive Therapy and Research 2004, 28(4):433-455.
31. Ramnero J., Ost L.G. Prediction of outcome in the behavioral treatment of panic disorder with agoraphobia. Cognitive Behavioral Therapy 2004, 33(4):176-180.
32. Rapee R.M., Brown T.A., Antony M.M., Barlow D.H. Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders. Journal of Abnormal Psychology 1992, 101(3):538-552.
33. Reiss S., Peterson R., Gursky D., McNally R. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behaviour Research and Therapy 1986, 24:1-8.
34. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P.,J.,J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(Suppl. 20):22-33.
35. Simon G.E. Choosing a first-line antidepressant: equal on average does not mean equal for everyone. Journal of the American Medical Association 2001, 286:3003-3004.
36. Simon G.E., Perlis R.H. Personalized medicine for depression: can wematch patients with treatments?. American Journal of Psychiatry 2010, 167:1445-1455.
37. Steketee G., Shapiro L.J. Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder. Clinical Psychology Review 1995, 15(4):317-346.
38. Taylor S., Koch W.J., McNally R. How does anxiety sensitivity vary across the anxiety disorders?. Journal of Anxiety Disorders 1992, 6:249-259.
39. Taylor S., Zvolensky M.J., Cox B.J., Deacon B., Heimberg R.G., Ledley D.R., et al. Robust dimensions of anxiety sensitivity: development and initial validation of the anxiety sensitivity Index-3. Psychological Assessment 2007, 19(2):176-188.
40. Teasdale J.D., Moore R.G., Hayhurst H., Pope M., Williams S.B., Segal Z.V. Metcognitive awareness and prevention of relapse in depression: empirical evidence. Journal of Consulting and Clinical Psychology 2002, 70:275-287.
41. Teasdale J.D., Segal Z.V., Williams J.M., Ridgeway V.A., Soulsby J.M., et al. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology 2000, 68(4):615-623.
42. Wolitzky-Taylor K.B., Arch J.J., Rosenfield D., Craske M.G. Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy. Journal of Consulting and Clinical Psychology 2012, 80(5):786-799. 10.1037/a0029418.